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Abstract- Two possibilities should be considered for the origin of SARS-CoV-2: natural evolution 
or laboratory creation. In our earlier paper titled "Unusual Features of the SARS-CoV-2 Genome 
Suggesting Sophisticated Laboratory Modification as a Biological Robot Rather than Natural 
Evolution and Delineation of its Probable Synthetic Route", we disproved the possibility of SARS-
CoV-2 arising naturally through evolution and instead proved that SARS-CoV-2 must have been a 
product of laboratory modification. Despite this and similar efforts, the laboratory creation theory 
continues to be downplayed or even diminished. This is fundamentally because the natural origin 
theory remains supported by several novel coronaviruses published after the start of the 
outbreak. These viruses (the RaTG13 bat coronavirus, a series of pangolin coronaviruses, and 
the RmYN02 bat coronavirus) reportedly share high sequence homology with SARS-CoV-2 and 
have altogether constructed a seemingly plausible pathway for the natural evolution of SARS-
CoV-2. Here, however, we use in-depth analyses of the available data and literature to prove that 
these novel animal coronaviruses do not exist in nature and their sequences have been 
fabricated. In addition, we also offer our insights on the hypothesis that SARS-CoV-2 may have 
originated naturally from a coronavirus that infected the Mojiang miners.  
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Revelation of these virus fabrications renders the 
natural origin theory unfounded. It also strengthens our earlier 
assertion that SARS-CoV-2 is a product of laboratory 
modification, which can be created in approximately six 
months using a template virus owned by a laboratory of the 
People’s Liberation Army (PLA). The fact that data fabrications 
were used to cover up the true origin of SARS-CoV-2 further 
implicates that the laboratory modification here is beyond 
simple gain-of-function research.   
The scale and the coordinated nature of this scientific 
fraud signifies the degree of corruption in the fields of 
academic research and public health. As a result of such 
corruption, damages have been made both to the reputation 
of the scientific community and to the well-being of the global 
community.   
Importantly, while SARS-CoV-2 meets the criteria of a 
bioweapon specified by the PLA, its impact is well beyond 
what is conceived for a typical bioweapon. In addition, records 
indicate that the unleashing of this weaponized pathogen 
should have been intentional rather than accidental. We 
therefore define SARS-CoV-2 as an Unrestricted Bioweapon 
and the current pandemic a result of Unrestricted Biowarfare. 
We further suggest that investigations should be carried out on 
the suspected government and individuals and the 
responsible ones be held accountable for this brutal attack on 
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Abstract- Two possibilities should be considered for the origin 
of SARS-CoV-2: natural evolution or laboratory creation. In our 
earlier paper titled "Unusual Features of the SARS-CoV-2 
Genome Suggesting Sophisticated Laboratory Modification as 
a Biological Robot Rather than Natural Evolution and 
Delineation of its Probable Synthetic Route", we disproved the 
possibility of SARS-CoV-2 arising naturally through evolution 
and instead proved that SARS-CoV-2 must have been a 
product of laboratory modification. Despite this and similar 
efforts, the laboratory creation theory continues to be 
downplayed or even diminished. This is fundamentally 
because the natural origin theory remains supported by 
several novel coronaviruses published after the start of the 
outbreak. These viruses (the RaTG13 bat coronavirus, a series 
of pangolin coronaviruses, and the RmYN02 bat coronavirus) 
reportedly share high sequence homology with SARS-CoV-2 
and have altogether constructed a seemingly plausible 
pathway for the natural evolution of SARS-CoV-2. Here, 
however, we use in-depth analyses of the available data and 
literature to prove that these novel animal coronaviruses do 
not exist in nature and their sequences have been fabricated. 
In addition, we also offer our insights on the hypothesis that 
SARS-CoV-2 may have originated naturally from a coronavirus 
that infected the Mojiang miners.  
I. Introduction
ARS-CoV-2 is a novel coronavirus and the 
causative agent of the COVID-19 pandemic. 
Despite its tremendous impact, the origin of 
SARS-CoV-2, however, has been a topic of great 
controversy. In our first paper titled "Unusual Features of 
the SARS-CoV-2 Genome Suggesting Sophisticated 
Laboratory Modification as a Biological Robot Rather than 
Natural Evolution and Delineation of its Probable
Synthetic Route"1, we used biological evidence and in-
depth analyses to show that SARS-CoV-2 must be a 
laboratory product, which was created by using a 
template virus (ZC45/ZXC21) owned by military research 
laboratories under the control of the Chinese 
Communist Party (CCP) government. In addition, 
resources and expertise are all in place in the Wuhan 
Institute of Virology (WIV) and related, other CCP-
controlled institutions allowing the creation of SARS-
CoV-2 in approximately six months. 
What have not been fully described in our earlier 
analyses are details of the novel animal coronaviruses 
published by the CCP-controlled laboratories after the 
outbreak1. While no coronaviruses reported prior to 2020 
share more than 90% sequence identity with SARS-CoV-
22,3, these recently published, novel animal 
coronaviruses (the RaTG13 bat coronavirus4, a series of 
pangolin coronaviruses5-8, and the RmYN02 bat 
coronavirus9) all share over 90% sequence identities 
with SARS-CoV-2. As a result, these SARS-CoV-2-like 
viruses have filled an evolutionary gap and served as the 
founding evidence for the theory that SARS-CoV-2 has a 
natural origin10-12. In this report, we provide genetic and 
other analyses, which, when combined with recent 
findings13-21, prove that these novel animal coronaviruses 
do not exist in nature and their genomic sequences are 
results of fabrication.
a) Evidence proving that the RaTG13 virus is fraudulent 
and does not exist in nature 
On February 3rd, 2020, Dr. Zhengli Shi and 
colleagues published an article in Nature titled “A 
pneumonia outbreak associated with a new coronavirus 
of probable bat origin” (manuscript submitted on 
January 20th)4, which was one of the first publications to 
identify SARS-CoV-2 as the pathogen causing the 
disease now widely known as COVID-19. Also reported 
in this article was a novel bat coronavirus named 
RaTG13, the genomic sequence of which was shown to 
be 96.2% identical to that of SARS-CoV2. The close 







































































SARS-CoV-2 Is an Robot Bioweapon
CoV-2 as suggested by the high sequence identity had 
led to a conclusion that SARS-CoV-2 has a natural 
origin. These striking findings have consequently made 
this article one of the most cited publications in the 
currently overwhelmed field of coronavirus research. 
Interestingly, an article published by Dr. Yong-Zhen 
Zhang and colleagues on the same issue of Nature, 
which also discovered SARS-CoV-2 as the responsible 
pathogen for COVID19, received much less citations2. 
This latter article made no mention of RaTG132. Instead, 
Zhang and colleagues showed that, evolutionarily, 
SARS-CoV-2 was closest to two bat coronaviruses, 
ZC45 and ZXC21, both of which were discovered and 
characterized by military research laboratories under the 
control of the CCP government3. Immediately after the 
publication of this article, Dr. Zhang’s laboratory was 
shut down by the CCP government with no explanations 
offered22.  
Since its publication4, the RaTG13 virus has 
served as the founding evidence for the theory that 
SARSCoV-2 must have a natural origin10. However, no 
live virus or an intact genome of RaTG13 have ever been 
isolated or recovered. Therefore, the only proof for the 
“existence” of RaTG13 in nature is itsgenomic sequence 
published on GenBank. 
b) The sequence of RaTG13 uploaded at GenBank can 
be fabricated 
In order to have the sequence of a viral genome 
successfully uploaded onto GenBank, submitters have 
to provide both the assembled genomic sequence (text 
only) and raw sequencing reads. The latter is used for 
quality control and verification purposes. However, due 
to the huge amount of work involved in assembling raw 
reads into complete genomes, no sufficient curation is in 
place to ensure the correctness or truthfulness of the 
uploaded viral genomes. Therefore, an entry on 
GenBank, which in this case is equivalent to the 
existence of an assembled viral genomic sequence and 
its associated sequencing reads, is not a definitive proof 
that this viral genome is correct or real. 
Sequencing of a viral RNA genome requires 
amplifying segments of it using reverse transcriptase 
PCR (RT-PCR) as the first step. The products of the RT-
PCR, which are double-stranded DNA, would 
subsequently be sent for sequencing. The resulted 
sequencing reads, each ideally revealing the sequence 
of a segment of the genome, are then used to assemble 
the genome of the virus under study (Figure 1A). 
Typically, some segments of the genome may not be 
covered by the initial round of sequencing. Therefore, 
gap filling will be carried out, where these missing 
segments will be amplified specifically and the DNA 
products subsequently sequenced. These steps are 
repeated until a complete genome can be assembled, 
ideally with a proper depth to ensure accuracy. 
However, this process leaves room for potential 
fraud. If one intends to fabricate an RNA viral genome 
on GenBank, he or she could do so by following these 
steps: create its genomic sequence on a computer, 
have segments of the genome synthesized based on 
the sequence, amplify each DNA segment through PCR, 
and then send the PCR products (may also be mixed 
with genetic material derived from the alleged host of 
the virus to mimic an authentic sequencing sample) for 
sequencing (Figure 1B). The resulted raw sequencing 
reads would be used, together with the created genomic 
sequence, for establishing an entry on GenBank. Once 
accomplished, this entry would be accepted as the 
evidence for the natural existence of the corresponding 
virus. Clearly, a viral genomic sequence and its 
GenBank entry can be fabricated if well-planned. 
Figure 1: Illustration of steps involved in the sequencing and assembly of coronavirus genomes. A. The normal 
process. B. A possible route of fabricating a viral genome by creating a genomic sequence first and obtaining raw 
sequencing reads guided by it. NGS: Next Generation Sequencing.  
The complete genomic sequence of RaTG13 
was first submitted to GenBank on January 27th, 2020. 
The raw sequencing reads were made available on 
February 13th, 2020 (NCBI SRA: SRP249482). However, 
the sequencing data for gap filling, which is 
indispensable in assembling a complete genome, was 
only made available on May 19th, 2020 (NCBI SRA: 
SRX8357956). The timing and the reversed order of 
events here are strange and suspicious.  
The raw sequencing reads of RaTG13 have 
multiple abnormal features16,21. Despite the sample 
being described as a fecal swab, only 0.7% of the raw 
sequencing reads are bacterial reads while the bacterial 
abundance is typically 70~90% when other fecal swab 
samples were sequenced16,21. In addition, in the 
identifiable region of certain sequencing reads, a vast 
majority of reads are eukaryotic sequences, which is 
also highly unusual in the sequencing of fecal swap-
derived samples16. Within these eukaryotic reads, 30% 
of the sequences are of non-bat origin and instead 
shown to be from many different types of animals 
including fox, flying fox, squirrels, etc. These abnormal 
features are significant and indicate that the raw 
sequencing reads should have been obtained via a 
route that is different from the normal one (Figure 1).   
No independent verification of the RaTG13 
sequence seems possible because, according to Dr. 
Zhengli Shi, the raw sample has been exhausted and no 
live virus was ever isolated or recovered. Notably, this 
information was known to a core circle of virologists 
early on and apparently accepted by them. It was then 
made public, months later, by Dr. Yanyi Wang, director 
general of the WIV, in an TV interview on May 23rd, 
202023. Dr. Shi also confirmed this publicly in her email 
interview with Science in July 202024.  
 
 
c) Other suspicions associated with RaTG13 
RaTG13 was reported by Dr. Zhengli Shi from 
the WIV4. Dr. Shi is a fellow of the American Academy of 
Microbiology and one of the most accomplished 
Chinese virologists. A peer-reviewed article authored by 
her and published on the top journal Nature, therefore, 
brought a great level of comfort for the coronavirus 
research community in accepting RaTG13 as a true, 
nature-born bat coronavirus. As a result, RaTG13, upon 
its timely publication, served as the founding evidence 
for the natural origin theory of SARS-CoV-2.   
However, as revealed in section 1.1, the 
reported sequence of RaTG13, which is the only proof of 
the virus’ existence in nature, is problematic and shows 
signs of fabrication.   
Intriguingly, despite the pivotal role of RaTG13 
in revealing the origin of SARS-CoV-2, the information 
provided for its discovery was surprisingly scarce with 
key points missing (location and date of sample 
collection, previous knowledge and publication of this 
virus, etc):  
“We then found that a short region of RNA-
dependent RNA polymerase (RdRp) from a bat 
coronavirus (BatCoV RaTG13)—which was previously 
detected in Rhinolophus affinis from Yunnan province— 
showed high sequence identity to 2019-nCoV. We 
carried out full-length sequencing on this RNA sample 
(GISAID accession number EPI_ISL_402131). Simplot 
analysis showed that 2019-nCoV was highly similar 
throughout the genome to RaTG13 (Fig. 1c), with an 
overall genome sequence identity of 96.2%.”4 Only in the 
source section of the NCBI entry for RaTG13 (GenBank 
accession code: MN996532.1), one could find that the 
original sample was a “fecal swab” collected on “July 
24th, 2013”. A closer look at the sequence reveals that 
RaTG13 shares a 100% nucleotide sequence identity 
with a bat coronavirus RaBtCoV/4991 on a short, 440-bp 
RNA-dependent RNA polymerase gene (RdRp) 
segment. RaBtCoV/4991 was discovered by Shi and 
colleagues and published in 201626. As described in the 
2016 publication, only a short 440-bp segment of RdRp 
of the RaBtCoV/4991 virus was sequenced then. Given 
the 100% identity on this short gene segment between 
RaBtCoV/4991 and RaTG13, the field has demanded 
clarification of whether or not these two names refer to 
the same virus. However, Dr. Shi did not respond to the 
request or address this question for months. The answer 
finally came from Peter Daszak, president of EcoHealth 
Alliance and long-term collaborator of Shi, who claimed 
that RaBtCoV/4991 was RaTG1327.   
RaBtCoV/4991 was discovered in the Yunnan 
province, China. In 2012, six miners suffered from 
severe pneumonia after clearing out bat droppings in a 
mineshaft in Mojiang, Yunnan, and three of them died 
soon afterwards28,29. Although it was initially suspected 
that a SARS-like bat coronavirus may be responsible for 
the deaths, no coronavirus was either isolated or 
detected from the clinical samples30. Also, first-hand 
record indicates failure of biopsy and no attempt of 
autopsy30, which are the gold standards in the diagnosis 
of coronavirus infections30. The pathogen responsible for 
the miners’ deaths therefore remained an unsolved 
case31. (Detailed analyses of the Mojiang Miner Passage 
hypothesis, which was based on the miners’ case, are 
provided in section 1.6.) Despite the failed diagnosis, 
this unknown pathogen nonetheless triggered immense 
interests in the virologists in China. Three independent 
teams, including that of Dr. Shi’s, made a total of six 
visits to this mineshaft26,28,31. The Shi group particularly 
looked for the presence of bat coronaviruses by 
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However, judging from Shi’s published 
protocol25, exhaustion of the fecal swap sample is highly
unlikely. According to this protocol, the fecal swab 
sample would be mixed with 1 ml of viral transport 
medium and the supernatant collected. Every 140 ul of 
the supernatant would then yield 60 ul of extracted 
RNA25.  For the subsequent step, RT-PCR, 5 ul of this 
RNA-containing solution is required per reaction25. 
Therefore, from one fecal swab sample, at least 80 RT-
PCR reactions could be carried out ([1000/140] x 
60/5=86). Such an amount is sufficient to support both 
the initial round of sequencing and the subsequent gap 
filling PCR. It would be sufficient to also allow 
reasonable attempts to isolate live viruses, although Dr. 
Shi claimed that no virus isolation was attempted24.  
Therefore. the RaTG13 virus and its published 
sequence are suspicious and show signs of fabrication.
amplifying and then sequencing a 440-bp RdRp 
segment29, which is a routine procedure the Shi group 
follows in their surveillance studies. (As shown in section 
2.1 of our first report1, this RdRp segment is also 
frequently used for phylogenetic analyses and is an 
attractive target for antiviral drug discovery, which may 
have contributed to the design of incorporating a unique 
RdRp into the genome of SARS-CoV-2.) Out of the many 
coronaviruses detected, only RaBtCoV/4991 seemed to 
belong to the group of SARS-related, lineage B β 
coronaviruses26.   
The reporting of RaTG13 is suspicious in three 
aspects.  
First, the whole genome sequencing of 
RaBtCoV/4991 should not have been delayed until 2020. 
Given the Shi group’s consistent interests in studying 
SARS-like bat coronaviruses and the fact that 
RaBtCoV/4991 is a SARS-like coronavirus with a 
possible connection to the deaths of the miners, it is 
highly unlikely that the Shi group would be content with 
sequencing only a 440-bp segment of RdRp and not 
pursue the sequencing of the receptor-binding motif 
(RBM)-encoding region of the spike gene. In fact, 
sequencing of the spike gene is routinely attempted by 
the Shi group once the presence of a SARS-like bat 
coronavirus is confirmed by the sequencing of the 440-
bp RdRp segment25,32, although the success of such 
efforts is often hindered by the poor quality of the 
sample.   
As quoted above, in the 2020 Nature 
publication, Shi and colleagues strongly suggested that 
the sequencing of the full genome was done in 2020 
after they discovered the resemblance between RaTG13 
and SARS-CoV-2 on the short RdRp segment4. This, if 
true, suggests that the quality of the sample should not 
be poor. Therefore, there is no technical obstacle for the 
whole genome sequencing of RaBtCoV/4991. Clearly, 
the perceivable motivation of the Shi group to study this 
RaBtCoV/4991 virus and the fact that no genome 
sequencing of it was done for a period of seven years 
(2013-2020) are hard to reconcile and explain.   
However, an intriguing revelation took place in 
June 2020. Specifically, filenames of the raw sequencing 
reads for RaTG13 uploaded on the database were 
found, which indicate that these sequencing 
experiments were done in 2017 and 201833. Likely 
responding to this revelation, in her email interview with 
Science24, Dr. Shi contradicted her own description in 
the Nature publication4 and admitted that the 
sequencing of the full genome of RaTG13 was done in 
2018.  
 
Figure 2: Sequence alignment comparing the RBMs of SARS (top) and RaTG13 (red arrow) to the RBMs of bat 
coronaviruses that Dr. Zhengli Shi published in high-profile journals between 2013 and 201825,32,34. Amino acid 
residues highlighted by Shi as critical for binding the human ACE2 receptor32 are labeled in red text on top. 




RBM is also the most variable region because it is under 
strong positive selection when the virus jumps over to a 
new host. Sequence alignment on this crucial RBM motif 
reveals that the RaTG13 virus rivals with the most highly 
regarded bat coronaviruses in terms of resemblance to 
SARS (Figure 2). RaTG13’s RBM not only is complete in 
reference to that of SARS but also is outstanding in its 
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Second, RaTG13 has a remarkable RBM as 
suggested by its reported sequence, and the Shi group 
have no reason to delay its publication until 2020. The 
most critical segment of a SARS-like β coronavirus is the 
RBM in the Spike protein as it is fully responsible for 
binding the host ACE2 receptor and therefore 
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preservation of five residues perceived by Dr. Shi as key 
in binding human ACE2 (hACE2)32 (Figure 2, residues 
labeled with red texts). At position 472, RaTG13 is the 
only bat coronavirus that shares a leucine (L) residue 
with SARS, while the other four key residues are also 
largely conserved between the two viruses. Importantly, 
similar conservation patterns revealed in related bat 
coronaviruses, Rs3367 and SHC014, had led to their 
publication in Nature in 201332. Furthermore, viruses with 
less “attractive” RBM sequences (having large gaps and 
poor in the preservation of key residues, bottom half of 
the sequences in Figure 2) were also published by Dr. 
Shi in other top virology journals between 2013 and 
201825,34. Therefore, if the genomic sequence of RaTG13 
had been available since 2018, it is unlikely that this 
virus, which has a possible connection to miners’ deaths 
in 2012 and has an alarming SARS-like RBM, would be 
shelfed for two years without publication. Consistent 
with this analysis, a recent study indeed proved that the 
RBD of RaTG13 (produced via gene synthesis based on 
its published sequence) was capable of binding 
hACE235.  
Third, no follow-up work on RaTG13 has been 
reported by the Shi group. Upon obtaining the genomic 
sequence of a SARS-like bat coronavirus, the Shi group 
routinely investigate whether or not the virus is capable 
of infecting human cells. This pattern of research 
activities has been shown repeatedly25,32,36-39. However, 
such a pattern is not seen here despite that RaTG13 has 
an interesting RBM and is allegedly the closest match 
evolutionarily to SARS-CoV-2. 
Clearly, these three aspects deviate from 
normal research activities and logical thinking, which are 
difficult to reconcile or explain. They should have 
contributed to the intentional omission of key information 
in the reporting of RaTG134. 
For publications of biological research, it is 
unethical for authors to change the name of a previously 
published virus without any notice or description. It is 
also unethical for authors to not cite their own 
publication where they had characterized and reported 
the same virus. The violations here by Shi and 
colleagues on the reporting of RaTG13 are especially 
aggravating as the discovery of RaTG13 was central to 
uncovering the origin of SARS-CoV-2. By the time of the 
publication, SARS-CoV-2 had already led to many 
deaths in the city of Wuhan and had shown an alarming 
potential of causing a pandemic. In her much-delayed 
response to Science published on July 31st, 202024, Dr. 
Shi finally commented on the name change and stated 
that changing the name to RaTG13 was meant to better 
reflect the time and location of sample collection (TG = 
Tongguan; 13 = 2013). However, such an intention 
does not seem to justify why the previous name of 
RaBtCoV/4991 was never mentioned in the 2020 article4 
and why they did not cite their own 2016 publication 
where RaBtCoV/4991 was first reported26. Dr. Shi’s 
recent clarification did not alter the fact that they have 
violated the reporting norms of biological research.  
In summary, a range of suspicions were
associated with the reporting of RaTG13, including the 
violations of scientific publication principles, the 
inconsistency in the descriptions of the sequencing 
dates, and the contradiction between the sequencing of 
its genome in 2018 and the publication of it in 2020 
when this virus has a striking RBM and a possible 
connection to pneumonia-associated deaths. Adding to 
these suspicions are the exquisite timing of its 
publication, the problematic nature of its reported 
sequence and raw sequencing reads, and the claim that 
no sample is left for independent verification. 
Collectively, these facts justify and legitimate the 
concern over the true existence of the RaTG13 virus in 
nature and the truthfulness of its reported genomic 
sequence. They also question the claim that the 
RaBtCoV/4991 virus and RaTG13 are equivalent.  
d) Genetic evidence proving the fraudulent nature of 
RaTG13 
This evidence was revealed after a close 
examination of the sequences of specific genes, 
especially spike, of relevant viruses. Specifically, we 
compared two viruses for the synonymous and non 
synonymous mutations on each gene, and we did so for 
two pairs of viruses. The first pair are bat coronaviruses 
ZC45 and ZXC21. The second pair are SARS-CoV-2 and 
RaTG13. The rationale for comparing these two pairs 
with each other is the following. First, ZC45 and ZXC21,
each sharing an 89% genomic sequence identity with 
SARS-CoV-2, are the closest relatives to SARS-CoV-2 
and RaTG13. Second, ZC45 and ZXC21 are 97% 
identical to each other, while SARS-CoV-2 and RaTG13 
are 96% identical. Not only the sequence identity in each 
case is comparable, but also the high sequence identity 
indicates that, within each pair, the sequence difference 
should be a result of random mutations during evolution, 
which ensures that synonymous and non-synonymous 
analyses here are appropriate and not complicated by 
abrupt evolutionary events (e.g. recombination). Indeed, 
sequence alignment confirms such a scenario – in both 
cases, the curve is smooth and the high sequence 










   
 
Figure 3: Simplot analyses show that high sequence identities are shared by two pairs of coronaviruses. A. the 
genomic sequence of RaTG13 is plotted against that of SARS-CoV-2. B. Genomic sequence of ZXC21 is plotted 
against that of ZC45.  
Detailed synonymous (syn, green curve) and 
non-synonymous (non-syn, red curve) analyses are 
shown in Figure 4. For each gene, the accumulations of 
syn and non-syn mutations, respectively, are illustrated 
when the codons are analyzed in a sequential order. For 
the spike genes, between ZC45 and ZXC21, the 
syn/non-syn ratio is 5.5:1 (Figure 4A left, 94 syn 
mutations and 17 non-syn mutations). Notably, the two 
curves progress along in a roughly synchronized 
manner. These features reflect, to a certain extent, the 
evolutionary traits resulted from random mutations 
during evolution in this sub-group of lineage B β 
coronaviruses.  
The same analysis on the spike genes of SARS-
CoV-2 and RaTG13, however, revealed a different 
scenario (Figure 4B right). Although the overall syn/non-
syn ratio is a similar 5.4:1 (221 syn mutations and 41 
non-syn mutations), the synchronization between the 
two curves is non-existent. In the second half of the 
sequence, which is over 700 codons (2,100 nucleotides) 
wide, the non-syn curve stays flat when the syn curve 
climbs continuously and significantly.   
Counting the syn and non-syn mutations of the 
S2 region (corresponding to residues 684-1273 of the 
SARS-CoV-2 Spike) reveals that, between ZC45 and 
ZXC21, there are a total of 27 syn mutations and 5 non-
syn mutations, yielding a syn/non-syn ratio of 5.4:1. In 
contrast, for the same S2 region, between SARS-CoV-2 
and RaTG13, there are a total of 88 syn mutations and 2 
non-syn mutations, yielding a syn/non-syn ratio of 44:1. 
The syn/non-syn ratios for S2, whole Spike, and other 
large viral proteins (Orf1a, Orf1b, and Nucleocapsid) are 
summarized in Table 1. While the ratios are comparable 
between the two groups for all other proteins, the ratios 
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Figure 4: Abnormal distribution of synonymous and non-synonymous mutations in Spike revealed by the comparison 
between RaTG13 and SARS-CoV-2. Synonymous and non-synonymous mutations are analyzed between closely 
related coronaviruses on large viral proteins: A. Spike (S), B. Orf1a, C. Orf1b, and D. Nucleocapsid (N). In each 
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panel, the left graph is the comparison between the two bat coronaviruses ZC45 (MG772933) and ZXC21 
(MG772934), while the right graph is the comparison between SARS-CoV-2 (NC_045512) and RaTG13 (MN996532). 
In each graph, the accumulative growth of synonymous mutations (green curve), non-synonymous mutations (red 
curve), and in-frame deletions (blue curve) are depicted, respectively. Initial sequence alignment was done using 
EMBOSS Needle, which was followed by codon alignment at www.hiv.lanl.gov. Synonymous nonsynonymous 
analyses were performed using SNAP also at www.hiv.lanl.gov40. 






S2 5.4:1 44.0:1 
Spike 5.5:1 5.4:1 
Orf1a 2.7:1 5.0:1 
Orf1b 7.1:1 10.8:1 
N 4.3:1 6.8:1 
The detailed syn/non-syn analyses for Orf1a, 
Orf1b, and N are shown in Figure 4B-D. It is also 
noteworthy that, similar to that of Spike, the approximate 
synchronization between two curves is observed for the 
Orf1a protein in the ZC45 and ZXC21 comparison 
(Figure 4B left) but not in the SARS-CoV-2 and RaTG13 
comparison (Figure 4B right).   
The S2 protein maintains trimmer formation of 
the Spike and, upon successive cleavages to expose 
the fusion peptide, mediates membrane fusion and cell 
entry. Although the S2 protein is more conserved 
evolutionarily than S1, the extremely high purifying 
pressure on S2 as suggested by the very high 
syn/nonsyn ratio is abnormal. In fact, Orf1b is known to 
be the most conserved protein in coronaviruses and yet 
the syn/non-syn ratio for it is only 10.8:1 when SARS-
CoV-2 and RaTG13 are compared, much lower than the 
ratio of 44:1 observed for S2 (Table 1). Furthermore, 
since RaTG13 and SARS-CoV-2 infect different species, 
no high purifying selection on S2 should be expected 
when these two viruses are compared against each 
other.   
Figure 5: Positive selection, not purifying selection, is observed for Spike in twenty randomly selected SARSCoV-2 
sequences. GenBank accession numbers are shown in Figure 6. Collection dates of these viruses range from 
December 2019 to July 2020.   
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Figure 6: Five amino acid mutations are observed in S2 (684-1273) in twenty randomly selected SARS-CoV-2 
sequences. They are at positions 829, 1020, 1101, 1176, and 1191. GenBank accession number for each isolate is 
shown in the sequence’s name following the country name.  
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Consistent with the above notion, a syn/non-syn 
analysis done for the Spike protein of twenty randomly 
selected SARS-CoV-2 sequences showed that S2 was 
under positive selection, not purifying selection, during 
the past eight months of human-to-human transmission 
(Figure 5). For the twenty SARS-CoV-2 isolates, amino 
acid mutations are observed at five different locations in 
S2 (Figure 6). In addition, a recent study analyzing 2,954 
genomes of SARS-CoV-2 revealed that mutations have 
been observed at 25 different locations in the S2 
protein41, further proving that amino acid mutations are 
tolerated in S2 and no high purifying pressure should be 
observed for S2. Evidently, the syn/non-syn ratio of 44:1 
revealed between SARS-CoV-2 and RaTG13 on the S2 
region is abnormal (Table 1) and a violation of the 
principles of natural evolution. 
A logical interpretation of this observation is that 
SARS-CoV-2 and RaTG13 could not relate to each other 
through natural evolution and at least one must be 
artificial. If one is a product of natural evolution, then the 
other one must be not. It is also possible that neither of 
them exists naturally.  
If RaTG13 is a real virus that truly exists in 
nature, then SARS-CoV-2 must be artificial.  
However, the reality is that SARS-CoV-2 is 
physically present and has first appeared prior to the 
reporting of RaTG134. This would then lead to the 
conclusion that RaTG13 is artificial, a scenario 
consistent with the overwhelming suspicion that this 
virus does not exist in nature and its sequence has been 
fabricated.  
The remaining possibility is, of course, that both 
SARS-CoV-2 and RaTG13 are artificial: one has been 
created physically and the other one exists only in the 
form of a fabricated sequence.  
It is highly likely that the sequence of the 
RaTG13 genome was fabricated by lightly modifying the 
SARS-CoV-2 sequence to achieve an overall 96.2% 
sequence identity. During this process, much editing 
must have been done for the RBM region of the S1/spike 
because the encoded RBM determines the interaction 
with ACE2 and therefore would be heavily scrutinized by 
others. An RBM too similar to that of SARS-CoV-2 would 
be troublesome because: 1) RaTG13 could be 
conceived as a product of gain-of function research; 2) 
it would leave no room for an intermediate host and yet 
such a host is believed to exist as the Spike/RBM needs 
to first adapt in an environment where the ACE2 
receptor is homologous to hACE2. In addition, 
modifying the sequence of the RBM is also beneficial as 
RaTG13 would otherwise appear to be able to infect 
humans as efficiently as SARS-CoV-2 does, escalating 
the concern of a laboratory leak. To eliminate such 
concerns, many non-syn mutations were introduced into 
the RBM region.  
Importantly, syn/non-syn analysis is frequently 
used, often at the ORF/protein level, to characterize the 
evolutionary history of a virus42-44. While editing the RBM, 
the expert(s) carrying out this operation must be 
conscious of the need to maintain a reasonable 
syn/non-syn ratio for the whole Spike protein. To achieve 
so, however, the expert(s) must have then strictly limited 
the number of non-syn mutations in the S2 half of Spike, 
which ended up flattening the curve (Figure 4A right). 
e) The receptor-binding domain (RBD) of RaTG13 does 
not bind ACE2 of horseshoe bats 
Consistent with the above conclusion that 
RaTG13 does not exist in nature and its sequence was 
fabricated, a recent study showed that the RBD of 
RaTG13 could not bind the ACE2 receptors of two 
different kinds of horseshoe bats, Rhinolophus macrotis 
and Rhinolophus pusillus45. Although the ACE2 receptor 
of Rhinolophus affinis (the alleged host of RaTG13) was 
not tested, it is unlikely that ACE2 of R. affinis would 
differ significantly from those of its close relatives and be 
able to bind the RaTG13 RBD.  
This result therefore implicates that RaTG13 
would not be able to infect horseshoe bats, 
contradicting the claim made by Shi and colleagues that 
the virus was detected and discovered from horseshoe 
bats. This is also consistent with the above conclusion 
that the genomic sequence of RaTG13 is fabricated and 
presumably computer-edited, which entails that the 
RBM/RBD suggested by the corresponding gene 
sequence may not be functional in binding the ACE2 
receptor of the claimed host.  
f) Conclusion and postulation of the fabrication 
process 
In conclusion, the evidence presented both here 
and from recent literature collectively prove that RaTG13 
does not exist in nature and its sequence has been 
fabricated.  
If the RaBtCov/4991 virus is equivalent to 
RaTG13, then RaBtCoV/4991 must be fraudulent as well.   
Apparently, in the actual process of sequence 
fabrication, the published sequence of the short 
RdRpsegment of RaBtCoV/4991 was completely 
inherited for RaTG13. This way, they could claim that 
RaTG13 was RaBtCoV/4991, which, according to the 
record, was discovered in 201326. If RaTG13 had been 
described as being discovered right around the time of 
the COVID-19 outbreak, greater suspicions would result 
as tracing the evolutionary origin of a zoonotic virus is 
difficult and usually takes years or decades. As 
described in section 2.1 of our earlier report1, the 
fabrication of RaTG13 should have been planned and 
executed in coordination with the laboratory creation of 
SARS-CoV-2.   
Such an approach is also safe because, except 
for the 440-bp RdRp segment, no other sequence 
information has ever been published for the rest of the 
RaBtCoV/4991 genome.   
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It is worth noting that, due to reasons detailed in 
section 1.2, they still preferred to obscure the history of 
RaTG13. However, they must have also anticipated that 
their violations of the publication norms would invite 
inquiries or requests for clarifications, the number of 
which, however, should be limited and manageable. 
RaBtCoV/4991 would then function as an additional 
layer of security for them in facing such inquiries and/or 
requests. 
Building upon the 440-bp RdRp sequence 
inherited from RaBtCoV/4991, the rest of the RaTG13 
genome was likely fabricated by lightly editing the 
sequence of SARS-CoV-2. Once the genomic sequence 
was finalized, DNA fragments could be synthesized 
individually according to the fabricated and edited 
sequence and then used as templates for PCR. 
Amplified DNA would then be mixed with certain raw 
material to give the sample a natural look (mimicking 
what is present in an actual RT-PCR, which is done 
using RNA extracted from fecal swabs as templates). 
Subsequently, this sample would be sent for 
sequencing. The resulted raw sequencing reads could 
then be uploaded together with the made-up genomic 
sequence onto GenBank to create an entry for the 
RaTG13 genome. 
g) The Mojiang Miner Passage (MMP) hypothesis is 
fatally flawed 
Recently, a theory has emerged, which 
proposed that SARS-CoV-2 was derived from viral 
passaging in the lungs of the infected Mojiang miners 
back in 201246. Specifically, authors believe that the 
RaBtCoV/4991 virus was indeed RaTG13 and was the 
virus causing pneumonia in the miners in 2012. While 
inside the lungs of the miners, the RaTG13 virus had 
evolved extensively, mimicking a viral passage process, 
and eventually became SARS-CoV-2. In this process, 
the RBD of the virus experienced strong positive 
selection, through which it became optimal in binding 
hACE2. Furthermore, the furincleavage site at the S1/2 
junction region of Spike had been acquired through 
recombination between the viral spike gene and the 
gene encoding the human ENaC protein, which has a 
furin-cleavage sequence closely resembling that of 
SARS-CoV-2. The end product of this passage was 
SARS-CoV-2, which the researchers isolated from the 
miners’ samples and brought back to the WIV. The 
authors have named this hypothesis as the Mojiang 
Miner Passage (MMP) hypothesis46.   
However, this MMP hypothesis has fatal flaws.  
First, the viral pathogen that caused the disease 
in the miners could not be defined or confirmed. 
According to the record, which was well documented in 
a Master’s Thesis written by the doctor in charge, 
samples from two patients (throat swabs and blood) 
were tested at the Center for Disease Control and 
Prevention of the Chengdu Military Region between May 
15th and May 20th, 2012, and yet none of the suspected 
viruses, including SARS, was detected30. Furthermore, 
the gold standard in the clinical diagnosis of 
coronavirus-caused pneumonia is biopsy and/or 
autopsy followed by confirmation by either RT-PCR or 
isolation of the virus. However, three biopsy tests were 
attempted but failed30. Autopsy tests were requested 
and yet all turned down by families of the deceased 
miners30. Due to such failure, both the Master’s Thesis 
and later a PhD Dissertation, which also looked into this 
issue although in an indirect manner, described the 
cause of the pneumonia as an unsolved case30,31.  
Second, antibody tests done for the miners do 
not support SARS or SARS-like coronavirus infection. 
According to the Master’s Thesis, samples from two 
miners were tested for antibodies against SARS30. The 
symptoms onset date for one miner (case 3, passed 
away) was around April 13th, 2012. The other miner 
(case 4, had severe symptoms and yet recovered) had 
symptoms onset around April 16th, 2012. Antibody tests, 
which were recommended later by Dr. Nanshan Zhong, 
were done at the WIV on June 19th, 2012. However, the 
two samples tested were only positive for IgM30. No 
positive IgG or total antibody were reported30. No 
antibody titer was reported either. Importantly, if the 
severe pneumonia was caused by coronavirus 
infections, by the time of the antibody tests on June 19th, 
2012, both IgM and IgG/total antibody should be 
detected. In fact, IgG/total antibody should be much 
more abundant and easier to detect47. On the other 
hand, IgM tests frequently result in false positives48. 
Therefore, the fact that only IgM, and no IgG/total 
antibody, was tested positive suggests that the 
described results were most likely false positives and 
the infections should not have been caused by SARS or 
a SARS-like coronavirus.  
It is noteworthy that the later PhD Dissertation31 
showed severe discrepancies with the Master’s Thesis 
in the descriptions of the same clinical tests:  
1. The PhD Dissertation described that samples from 
four miners (throat swab and blood) were sent to 
the Center for Disease Control and Prevention of the 
Chengdu Military Region for nucleic acid tests. 
However, the Master’s Thesis indicated that 
samples were only taken from two miners30.   
2. The PhD Dissertation described samples from four 
miners were tested for anti-SARS antibodies at the 
WIV and all were IgG positive. However, the 
Master’s Thesis indicated that only samples from 
two miners were tested at the WIV and both were 
only IgM positive30.  
Importantly, the Master’s Thesis was written in 
2013 in Yunnan by the doctor who was in charge of the 
six hospitalized miners30. The PhD dissertation, however, 
was written in 2016 in Beijing based only on the clinical 
record. The author of the Dissertation had no direct 
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involvement in the treatment of the miners or in any of 
the described tests31. It is therefore highly likely that 
author of the PhD dissertation did not verify the clinical 
data he presented, which makes this PhD dissertation 
an unreliable source of information concerning the 
Mojiang miners’ case.  
Third, if SARS-CoV-2 was already present in the 
miner’s body in 2012, it would have certainly caused an 
epidemic or even pandemic then. Given the extremely 
high transmissibility of SARS-CoV-2, it would be 
impossible for the doctors, nurses, family members of 
the miners, etc. to have avoided contracting the virus 
without the protection of proper PPE. If an epidemic 
indeed happened in 2012, it could not have gone 
unnoticed given the high transmissibility and lethality 
(three out of the six pneumonia patients died despite of 
intense medical care provided for them).   
Fourth, as shown in sections 1.1-1.5, RaTG13’s 
sequence is clearly fabricated and the virus does not 
exist in nature. The RaBtCoV/4991 virus, which was 
detected in 2013, is not the RaTG13 virus that is defined 
by its reported genomic sequence. No complete 
genomic sequence of RaBtCoV/4991 has ever been 
reported likely due to the poor quality of the sample, 
which happens often as the RNA genome decays easily. 
It is highly likely that no high homology is shared 
between the actual RaBtCoV/4991 virus and SARS-CoV-
2. This judgement is based on the fact that no viruses 
reported prior to 2020 share more than 90% sequence 
identity with SARS-CoV-2 despite the extensive 
surveillance studies of coronaviruses for the past two 
decades. Therefore, even if RaBtCoV/4991 was the 
pathogen responsible for the pneumonia of the miners, 
the theory that it has evolved in a single person’s lung 
into SARS-CoV-2 is far beyond being reasonable.  
Fifth, it is impossible for the Spike protein of the 
virus to obtain a unique furin-cleavage site at the S1/S2 
junction through recombination with the gene encoding 
the ENaC protein of the host cell (ENaC carries a furin 
cleavage site closely resembling the one seen in SARS-
CoV-2). This is because recombination requires a 
significant level of sequence similarity between the two 
participating genes and yet no such similarity is present 
between coronavirus Spike and human ENaC. The 
molecular basis for recombination is non-existent. 
(Although recombination between ENaC and coronavirus 
Spike is impossible, it is suspicious that a viral protein 
and a host protein would share the same sequence for 
their furin-cleavage sites. It is possible, though, that the 
sequence of the furin-cleavage site in ENaC49, which is 
known since 199750, could have been used in the design 
of the furin-cleavage site in the Spike of SARSCoV-2. 
Such a design may be considered sophisticated as 
ENaC co-expresses with ACE2 in many different types of 
cells49.)  
Sixth, if SARS-CoV-2 has indeed evolved from 
RaBtCoV/4991 in the miner’s lungs, it would look, from 
every aspect, like a naturally occurring virus. In that 
case, there would be no need to commit sequence 
fabrication for RaTG13 and for the other novel 
coronaviruses (parts 2 and 3) to falsify a natural origin 
for SARS-CoV-2.   
Finally, as revealed in our earlier report1, 
evidence exists in the genome of SARS-CoV-2, 
indicating that genetic manipulation is part of the history 
of SARS-CoV-2. 
II. Evidence Proving that Recently 
Published Pangolin Coronaviruses 
are Fraudulent and do not Exist       
in Nature 
While RaTG13 was reported to share a high 
sequence identity with SARS-CoV-2 and thereby hinted 
a natural origin of SARS-CoV-2, significant questions 
remained unanswered:   
• No intermediate host has been found although one 
was believed to exist and function as the reservoir of 
the virus before it spilled over to humans.   
• Despite the overall genomic resemblance of the two 
viruses, the RBD (particularly the RBM within it) of 
RaTG13 differs significantly from that of SARS-CoV-
2. The evolutionary origin of the SARS-CoV-2 RBD, 
which is optimal in binding hACE2, remained 
unclear.   
• A critical furin-cleavage site, which is present at the 
S1/S2 junction of SARS-CoV-2 Spike and 
responsible for the enhanced viral infectivity and 
pathogenicity51-57, is absent in RaTG13 (as well as in 
all known lineage B β coronaviruses58). The 
evolutionary origin of this furin-cleavage site also 
remained mysterious.  
Not long after these questions emerged, several 
laboratories published novel coronaviruses allegedly 
found in Malayan pangolins that were smuggled from 
Malaysia and confiscated by the Chinese custom58. 
Although these novel coronaviruses share relatively 
lower overall sequence identities (~90%) with SARS-
CoV-2 in comparison to RaTG13 (96.2% identical to 
SARS-CoV-2), the RBD of the pangolin coronaviruses 
resembles greatly the SARS-CoV-2 RBD (97.4% 
identical). In the most critical RBM region, all amino 
acids except one are identical between the pangolin 
coronaviruses and SARS-CoV-25-8. These observations 
led the authors to conclude 1) that pangolins are the 
likely intermediate host for the zoonotic transfer of 
SARS-CoV-25,7 and 2) that a RaTG13-like ancestor 
coronavirus might have acquired the RBD from a 
pangolin coronavirus through recombination to 
eventually become SARS-CoV-25-8.   
Here, in part 2 of the report, we describe 
literature evidence and provide genetic analyses to 
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prove that these novel pangolin coronaviruses are 
results of fabrication.  
a) A single batch of pangolin samples were used in all 
studies and the deposited sequencing data showed 
heavy contamination and signs of fabrication 
In October 2019, a team formed by three 
researchers from two institutions (Guangdong Institute 
of Applied Biological Resources and Guangzhou Zoo) 
reported, for the first time, the detection of coronavirus 
infections in pangolins that were allegedly smuggled 
from Malaysia and confiscated in the Guangdong 
province in March 201959. Twenty-one pangolin samples 
were sequenced and five were positive for coronavirus 
infections (Table 2: lung 2, 7, 8, 9, and 11), although 
Sendai virus infection was also reported. However, 
neither the sequences of the coronaviruses nor raw 
sequencing data were made available to the public for a 
period of three months. The raw data (NCBI BioProject 
PRJNA573298) was finally released on January 22nd, 
2020 after the COVID-19 outbreak started, while the 
article submission date was September 30th, 2019 and 
the publication date was October 24th, 201959.   
Between March and May 2020, four seemingly 
independent studies were published, all of which 
reported novel pangolin coronaviruses and their 
assembled genomic sequences5-8. However, after a 
closer look, we found that all four studies derived viral 
sequences from the same set of pangolin samples first 
reported in the October 2019 publication59, which has 
been confirmed by a recent article13.   
In one study6, Liu et al. (the same authors of the 
October 2019 publication59) re-assembled the genome 
of a pangolin coronavirus by pooling two samples from 
the original 2019 study and one sample obtained from 
another Malayan pangolin rescued in July 2019. 
However, although the authors stated that the more 
recent raw sequencing data had been deposited at the 
NCBI database6, we could not find this data using the 
accession number (2312773) provided. The same 
difficulty has been reported by others13. Therefore, it 
cannot be verified whether the July 2019 dataset truly 
exists and has contributed to the assembly of the 
reported genome.  
In two other studies, Lam et al.5
 
and Zhang et 
al.8
 
each re-assembled the genome of a pangolin 
coronavirus using only the published dataset from the 
October 2019 study59. Lam et al. also reported detection 
of coronaviruses from smuggled Malayan pangolins that 
were confiscated in the Guangxi province5, although 
these viruses showed lower sequence identities to 
SARS-CoV-2 both at the whole genome level (~86%) 
and in the critical RBD region. It is noteworthy that this 
study was done as a collaboration between Dr. Yi 
Guan’s group from the University of Hong Kong and Dr. 
Wuchun Cao’s group from the Academy of Military 
Medical Sciences (AMMS), Beijing, China5. Somehow, 
all authors affiliated with the AMMS were excluded from 
the list of authors when the article was first submitted60, 
although their names eventually appeared in the final 





It is noteworthy that the study by Xiao et al. was 
also done in collaboration with the AMMS. Prior to the 
publication of the manuscript, this work was first 
publicized in a press conference61,62. As revealed in this 
conference, four principle investigators contributed to 
the work and one of them was Dr. Ruifu Yang from the 
AMMS. However, like what happened to Dr. Cao and his 
AMMS colleagues in the Lam et al. study5, Dr. Yang’s 
name was excluded in the submitted manuscript of Xiao 
et al.63. Yet, unlike the other case, the AMMS 
researcher’s name did not re-appear in the final 
publication7. It is also noteworthy that the two AMMS 
principle investigators here, Dr. Yang and Dr. Cao, are 
long-term collaborators and most of their collaborative 




Among the four studies, only two assembled 
complete genomes by performing gap filling using 
PCR6,7. However, neither group made their gap filling 
sequences available13, rendering independent 
verification impossible. Notably, the delayed publishing 
of raw sequencing reads long after the publication of 
genomic sequences has occurred in the reporting of 
RaTG13 as well.  
Adding to the above problems was the poor 
quality of the raw sequencing data, which has been 
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In the fourth study, Xiao et al. claimed to have 
examined tissue samples kept from diseased pangolins 
and obtained raw sequencing data for the subsequent 
assembly7. However, they did not describe how the 
samples were acquired. In their Extended Data Table 3, 
they listed the metagenome sequencing data used in 
the study7, which, surprisingly, do not match with the 
actual data that they uploaded in the database (Table 
2). Samples M1, M5, M6, M10, and Z1 can be found in 
the data they deposited, but not M2, M3, M4, and M8. 
Furthermore, Xiao et al. apparently were inconsistent 
with the reporting of these raw sequencing reads. For 
samples M1, M6, pangolin3, and pangolin5, they 
counted paired ends numbers, which reflect the actual 
number of sequenced DNA fragments in the library. For 
the rest of samples, the authors counted reads numbers 
instead (In Illumina sequencing, there are two reads per 
fragment). For samples M2, M3, M4, and M8 in this 
latter group7, when the reads numbers were converted 
to pairedends numbers (divided by 2), they each match 
perfectly with lung07, lung02, lung08, and lung11, 
respectively, from the October 2019 study59 (Table 2). 
Clearly, Xiao et al. used the data published in a previous 
study but failed to disclose this necessary information in 
their publication7. In fact, they intentionally presented the 
“number of reads” in a different format to presumably 
make readers overlook the fact that the same 
sequencing dataset was used.  
described recently13,14,20. We also analyzed the 
composition of the sequencing reads of the deposited 
libraries. By performing taxonomy analysis on the NCBI 
SRA database, we also found that samples from Liu et 
al.6 that are positive for coronavirus reads are all positive 
for reads that map to human genome (Table 2). In great 
contrast, the rest of the samples, which are negative for 
viral reads, also have no human reads detected. The 
same correlation is found in data presented by Xiao et 
al7. Although samples M5 (pangolin 6) and M6 
(pangolin2) are negative for human reads, these two 
samples have very few viral reads, which would hardly 
contribute to the viral genome assembly. Clearly, the 
human contamination should not be due to sample 
handling as none of the coronavirus-negative samples, 
which must have been handled similarly, contain such 
contamination. The consistent co-existence of viral 
reads and human reads are highly suspicious. 
Table 2: Analyses of the raw sequencing data deposited by Liu et al 
 
These observations raise red flags not only on 
the credibility of the assembled sequences but also on 
the authenticity of these novel pangolin coronaviruses. It 
is also noteworthy that the manuscript submission dates 
for all four studies were between February 7th and 
February 18th5-8, suggesting that their publications might 
have been coordinated.  
b) No coronavirus was detected in an extensive 
surveillance study of Malayan pangolins 
While these SARS-CoV-2-like pangolin 
coronaviruses were described as being detected in 
smuggled Malayan pangolins59, a recent study strongly 
refuted the presence of such pangolin coronaviruses in 
nature. A team led by Dr. Daszak examined 334 
pangolin samples, which were collected in Malaysia and 
Sabah from August 2009 to March 201968. Surprisingly, 
no coronaviridae, or any of the other families of viruses 
(filoviridae, flaviviridae, orthomyxoviridae, and 
paramyxoviridae), were detected in any of these 
samples. This is in stark contrast with the October 2019 
publication where both coronavirus infection and Sendai 
virus infection were reportedly detected in the smuggled 
Malayan pangolins59, which eventually led to the 
discovery and publication of the novel pangolin 
coronaviruses5-8. The finding of Lee et al.68 adds 
significantly to the existing suspicions and substantiates 
the possibility that these pangolin coronaviruses do not 
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c) The RBD of the reported pangolin coronaviruses 
binds poorly to pangolin ACE2
If pangolin coronaviruses truly exist and have 
recently spilled over to infect humans, their Spike 
protein, especially the RBD within Spike, should bind to 
pangolin ACE2 (pACE2) more efficiently than to hACE2. 
However, recent findings have contradicted this theory. 
In an in silico study, Piplani et al. calculated, following 
homology structural modeling, the binding energies 
involved in the association between SARS-CoV-2 Spike 
and ACE2 from either human or various animals69. 
Interestingly, the most favorable interaction that SARS-
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not with ACE2 from pangolin or any other suspected 
intermediate host. Furthermore, another study revealed, 
using a robust in vitro binding assay, that the RBD of 
SARS-CoV-2 binds much tighter (greater than 9-fold) to 
hACE2 than to pACE245. Although the RBD of the 
pangolin coronaviruses is not 100% identical to that of 
SARS-CoV-2, the RBMs of the two viruses, which is the 
most essential segment responsible for ACE2 
interactions, differ only by one amino acid5-8. Therefore, 
the poor binding efficiency observed between the RBD 
of SARS-CoV-2 and pACE245 infers that the RBD of the 
reported pangolin coronaviruses must bind to pACE2 
fairly inefficiently. Indeed, a very recent study confirmed 
the case: the RBD of the pangolin coronavirus binds 
pACE2 ten-fold weaker than to hACE270. These 
observations once again refute the claim that pangolins 
are the probable intermediate host for SARS-CoV-2. 
More importantly, the latter two studies strongly suggest 
that these viruses might not be able to establish 
infections in pangolins, which adds significantly to the 
suspicion that the published sequences of the pangolin 
coronaviruses may have been fabricated and these 
viruses do not exist in nature.
d) Genetic evidence proving the fraudulent nature of 
the pangolin coronaviruses
Evolutionarily, within the coronavirus genome, 
the RBD of Spike is under the strongest positive 
selection as it needs to adapt for binding a new receptor
whenever the virus crosses the species barrier and 
enters a new host. In lineage B β coronaviruses, the 
most essential segment for receptor recognition is the 
RBM, which fully determines the binding with ACE2. 
Strikingly, when the RBM sequence of the pangolin virus 
MP7896 is compared to that of SARS-CoV-2, no positive 
selection is observed (Figure 7A). Instead, the analysis 
revealed very strong purifying selection with 24 syn 
mutations and only one non-syn mutation. In contrast, 
when two related bat coronaviruses, BM48-3171 and
BtKY7272, are compared in a similar manner, strong 
positive selection is observed as expected (Figure 7B). 
Here, while there are 25 syn mutations, which is 
comparable to that between MP789 and SARS-CoV-2, 
the number of non-syn mutations is 30 (Figure 7B). 
Evidently, the species difference between pangolin and 
human is greater than that between the hosts of BM48-
31 and BtKY72, which are two different species of bats. 
Therefore, greater positive selection should be expected 
between MP789 and SARS-CoV-2 than that between 
BM4831 and BtKY72. The strong purifying selection
observed between MP789 and SARS-CoV-2 is, 
therefore, contradictory to the principles of natural 
evolution. 
 
Figure 7: The extremely high purifying pressure observed for the RBM in the comparison of pangolin coronavirus 
MP789 and SARS-CoV-2 contradicts the principles of natural evolution. Synonymous and nonsynonymous mutations 
in the RBM region are analyzed between related coronaviruses: A. pangolin coronavirus MP789 (MT121216.1) and 
SARS-CoV-2 (NC_045512.2), B. bat coronaviruses BM48-31 (NC_014470.1) and BtKY72 (KY352407.1), and C. bat 
coronaviruses ZC45 and ZXC21. D. Alignment of the RBM sequences from all six viruses. The beginning and end of 
the RBM are labeled following the sequence of the SARS-CoV-2 Spike. 
Table 3: Summary of syn/non-syn mutations in the RBM in three sets of pair-wise comparisons 
Viruses being compared Genomic sequence identity 
# of syn mutations 
in the RBM 
# of non-syn mutations 
in the RBM 
Syn/nonsyn 
ratio 
MP789 vs. SARS-CoV-2 90.1% 24 1 24:1 
BM48-31 vs. BtKY72 82.4% 25 30 0.8:1 
ZC45 vs. ZXC21 97.5% 12 3 4:1 
We further looked at the syn and non-syn 
mutations for the RBM in coronaviruses infecting the 
same species. Here, we compared the closely related 
coronaviruses ZC45 and ZXC21, which infect the same 
species of bats3, on their RBM segments (Figure 7C). 
Here, twelve synonymous mutations and three non 
synonymous mutations are observed, yielding a 
syn/non-syn ratio of 4:1. Such a value likely represents 
the approximate upper limit for the purifying selection in 
the RBM that such coronaviruses could possibly 
experience (Table 3). In addition, no purifying selection 
is observed in the RBM for the randomly selected twenty 
SARS-CoV-2 sequences (Figure 5, codon range 437-
507).   
Therefore, the extremely high syn/non-syn ratio 
(24:1) observed between MP789 RBM and SARSCoV-2 
RBM indicates that at least one of the two viruses is 
artificial.   
We believe that, to falsify the natural existence 
of the unique RBD/RBM of SARS-CoV-2, the amino acid 
sequence of the pangolin coronavirus RBD/RBM had 
been fabricated to closely resemble that of SARS-CoV-2. 
At the same time, the expert(s) carrying out this 
operation also wanted to create an appropriate level of 
divergence between the pangolin virus and SARS-CoV-2 
at the nucleotide level and thereby introduced a 
significant amount of syn mutations in the RBM. The 
abnormality revealed in Figure 7A and Table 3 likely 
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Figure 8: Abnormal distribution of synonymous and non-synonymous mutations in Spike associated with pangolin 
coronaviruses. A. Comparison between MP789 and P4L (MT040333.1). B. Comparison between the two bat 
coronaviruses BM48-31 and BtKY72. 
 
 
Protein MP789 vs. P4L BM48-31 vs. BtKY72 
S2 23.0:1 4.7:1 
Spike 2.1:1 2.0:1 
Orf1a 2.4:1 1.8:1 
Orf1b 7.6:1 5.8:1 
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Table 4: Ratios of syn/non-syn mutations observed in different viral proteins as revealed by pair-wise comparisons 
involving pangolin and bat coronaviruses
Similar syn/non-syn analyses on the overall 
spike further revealed the fraudulent nature of these 
novel pangolin coronaviruses. Here we compared two 
representative pangolin coronaviruses MP7896 (a 
Guangdong isolate) and P4L5 (a Guangxi isolate) as 
genomic sequences within each group of isolates share 
very high sequence identities13. As shown in Figure 8A, 
similar to the abnormal pattern observed between 
RaTG13 and SARS-CoV-2 (Figure 4A right), syn and 
non-syn curves exhibit drastically different trajectories 
and the non-syn curve abruptly flattens in the S2 half of 
the sequence.  
For comparison, we also analyzed the spike
genes of two SARS-like bat coronaviruses, BM48-31 and 
BtKY72. The two pangolin coronaviruses, MP789 and 
P4L, are 85.2% identical on the overall genome, while 
bat coronaviruses BM48-31 and BtKY72 are 82.4% 
identical. The comparison here is therefore appropriate. 
Analysis of the two bat viruses show that the two curves 
grow naturally in a relatively concerted manner with no 
excessive flattening of the red curve observed (Figure 
8B).  
Counting the number of syn and non-syn 
mutations in each pair of comparisons further illustrated 
the unnatural characteristics associated with the 
pangolin coronaviruses (Table 4). While the S2 protein is 
not expected to be more conserved than Orf1b, the 
syn/non-syn ratio for S2 observed in the comparison 
between MP789 and P4L is abnormally high (207 syn 
mutations and 9 non-syn mutations; syn/non-syn = 
23:1), which is far exceeding what is observed for Orf1b 
(7.6:1). 
As the two bat coronaviruses here were 
discovered in nature independently by research groups 
outside of China71,72, the features displayed in Figure 8B 
likely represent the approximate evolutionary trait of two 
coronaviruses at this level of overall divergence. 
According to the logic described earlier, the great 
contrast between Figure 8A and 8B and the abnormal 
syn/non-syn ratio of 23:1 (Table 4) further prove that, 
between MP789 and P4L, at least one is artificial, 
although we believe both groups of pangolin 
coronaviruses represented by MP789 and P4L, 
respectively, are non-natural and fabricated.
e) Summary and discussion
A single source of samples was used for all 
studies (some spuriously independent) reporting novel 
pangolin coronaviruses. The formats of sequencing 
reads were manipulated with a clear intention to hide the 
fact that the same dataset was used in different studies. 
The raw sequencing data is missing for certain critical 
pieces, poor in quality, and suspicious in terms of the 
amounts and types of contaminations present. The RBD 
© 2021 Global Journals
pieces, poor in quality, and suspicious in terms of the 
amounts and types of contaminations present. The RBD 
encoded by the reported sequence of pangolin 
coronaviruses could not bind pACE2 efficiently. As 
revealed by syn/non-syn analyses, sequences of the 
RBM and S2 regions of these pangolin coronaviruses 
exhibit features that are inconsistent with natural 
evolution. Finally, no coronavirus was detected in a 
large, decade-long surveillance study of Malayan 
pangolins. These observations and evidence converge 
to prove that these recently reported pangolin 
coronaviruses do not exist in nature and their sequences 
must have been fabricated.  
It is noteworthy that the abnormal syn/non-syn 
feature revealed for S2 in the comparison between 
MB789 and P4L (Figure 8A) resembles greatly that 
exhibited by the comparison between RaTG13 and 
SARS-CoV-2 (Figure 4A right). Judging based on this 
reoccurring pattern, we believe that the sequence 
fabrications in both cases (RaTG13 and pangolin 
coronaviruses) were most likely carried out by the same 
person or group, whose misconception of the spike 
gene evolution persisted in multiple such practices and 
resulted in the unnatural look of the syn/non-syn curves 
and numbers (Figure 4, Table 1, Figure 8, and Table 4).  
III. Evidence Revealing the Fraudulent 
Nature of the Novel Bat 
Coronavirus RmYN02 
While the publications of the fabricated pangolin 
coronaviruses might have seemingly fulfilled the 
scientific quests for an intermediate host for the 
zoonosis of SARS-CoV-2 as well as for an evolutionary 
origin of its RBD, it had remained suspicious and 
unexplainable how SARS-CoV-2 could have acquired 
the furin-cleavage site (-PRRAR/VS-) at the S1/2 junction 
through natural evolution. It is evident that, although 
furin-cleavage site has been found in certain other 
lineages of coronaviruses at the S1/2 junction, lineage B 
β coronaviruses clearly lack the ability to develop this 
motif at this location naturally58.  
In early June, another novel bat coronavirus, 
RmYN02, was reported9, which shares a 93.3% 
sequence identity with SARS-CoV-2 and appears to be 
the second closest bat coronavirus to SARS-CoV-2 (the 
closest is allegedly RaTG13). This finding adds yet 
another member to the rapidly growing sub-lineage of 
SARS-CoV-2-like coronaviruses (Figure 9), which has 
been completely vacant and practically nonexistent prior 
to the current pandemic. In addition, importantly, 
RmYN02 carries a unique sequence -PAA- at the S1/S2 
junction, which remotely resembles the inserted -PRRA- 
sequence at the same location in the SARS-CoV-2 
Spike. Despite the fact that -PAA- in RmYN02 only 
partially resembles the -PRRA- insertion in SARS-CoV-2 
and does not appear to be an actual insertion if properly 
aligned18, the authors nonetheless claimed that the 
natural occurrence of -PAA- in RmYN02 proves that the -
PRRA- sequence could very likely be acquired and 
“inserted” into the same location in SARS-CoV-2 
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Figure 9: Phylogenetic analysis of SARS-CoV-2 and representative viruses from the subgenus sarbecoronavirus. 
Figure redrew from Zhou et al9. Colored viruses were all reported after the COVID-19 outbreak. 
The fact that a poor alignment was used to 
make a disproportional, strong argument for an 
evolutionary origin of the furin-cleavage site, which 
appeared to be the last missing piece of the puzzle, is 
suspicious. Furthermore, despite the significance of the 
spike sequence of RmYN02 in supporting the central 
conclusion of the publication, the raw sequencing reads 
for spike has not been made available although the 
authors stated otherwise in the article9. This is yet 
another repeat of the pattern that has been exhibited in 
the reporting of both RaTG13 and pangolin 
coronaviruses, where the genomic sequence would be 
published first and the raw sequencing reads would not 
be made available months afterwards.  
Given that the CCP-controlled laboratories have 
repeatedly engaged in fabrication of coronaviruses to 
feed the missing pieces for the puzzle, the above 
suspicion opens up the possibility that the RmYN02 
virus could have been fabricated as well. Judging from 
the fact that its sequence identity to SARS-CoV-2 
(93.3%) is lower than that between RaTG13 and SARS-
CoV-2 (96.2%), we suspected that the sequence of 
RmYN02 might have been fabricated by modifying the 
sequence of RaTG13. Such an approach could easily 
ensure that the evolutionary distance between RmYN02 
and SARS-CoV-2 is greater than that between RaTG13 
and SARS-CoV-2. It also ensures that RmYN02 and 
RaTG13 would appear to be evolutionarily close, 
consistent with the claim that they both infect bats 
although of different species.   
We therefore compared the spike genes of 
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syn and non-syn mutations. The severe divergence at 
the S1 portion between the two viral sequences did not 
allow the S1 sequences to be properly codon-aligned. 
Therefore, only the S2 half was analyzed (Figure 10). For 
the beginning 200 codons of S2, both types of 
mutations accumulate steadily and gradually. However, 
for the final 378 codons, once again, the non-syn curve 
flattens and the concerted growth of the two curves has 
disappeared. In this region, there are 57 syn mutations 
and only one non-syn mutation. The syn/non-syn ratio of 
57:1 for a region as wide as 378 codons (1,344 
nucleotides) is severely inconsistent with what is 
observed naturally (Figure 4A left and Figure 8B)41. 
 
Figure 10: Analysis of synonymous and non-synonymous mutations in S2 between RmYN02 and RaTG13. The 
abrupt change of trajectory of the non-synonymous mutation (red) curve and its subsequent flattening are observed. 
Logically, between RaTG13 and RmYN02, at 
least one must be artificial. Here, however, we are 
convinced that both viruses are artificial. As shown in 
part 1, the sequence of RaTG13 must have been 
fabricated. Therefore, the fact that the last 378 codons 
of RmYN02’s S2 are identical, with the exception of one, 
to that of RaTG13 proves that the RmYN02 sequence 
must be artificial as well. This also proves our earlier 
suspicion that the RaTG13 sequence should have been 
used as the template for the fabrication of the RmYN02 
sequence. RaTG13 was published in late January4, while 
RmYN02 was published in early June (manuscript 
submitted in April)9. Therefore, enough time is in 
between for the sequence fabrication to be carried out. 
While introducing nucleotide changes to create 
the apparent divergence between the two viruses, the 
expert(s) may have overly restricted amino acid changes 
in this part of Spike. Again, the abrupt change of 
trajectory of the non-syn curve and its excessive 
flattening later in the sequence likely reflect their 
overestimation of the purifying selection pressure on S2. 
The fact that this abnormal pattern has been observed 
in all three cases (Figure 4A right, 8A, and 10) reiterates 
the point raised in section 2.5 that all sequence 
fabrications may have been carried out by the same 
person or group. 
IV. Final Discussion and Remarks 
a) All fabricated coronaviruses share a 100% amino 
acid sequence identity on the E protein with ZC45 
and ZXC21 
Evidence herein clearly indicates that the novel 
coronaviruses recently published by the CCP controlled 
laboratories are all fraudulent and do not exist in nature. 
One final proof of this conclusion is the fact that all of 
these viruses share a 100% amino acid sequence 
identity on the E protein with bat coronaviruses ZC45 
and ZXC21, which, as revealed in our earlier report1, 
should be the template/backbone used for the creation 
of SARS-CoV-2 (Figure 11). Despite its conserved 
function in the viral replication cycle, the E protein is 
tolerant and permissive of amino acid mutations1. It is 
therefore impossible for the amino acid sequence of the 
E protein to remain unchanged when the virus has 
allegedly crossed species barrier multiple times 
(between different bat species, from bats to pangolins, 
and from pangolins to humans). The 100% identity 
observed here, therefore, further proves that the 
sequences of these recently published novel 
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Figure 11: All novel coronaviruses recently published by the CCP-controlled laboratories share a 100% amino acid 
sequence identity on the E protein with ZC45 and ZXC21. Additional accession numbers of viruses: SARSCoV-2 
(NC_045512.2), Pangolin-CoV (EPI_ISL_410721), P5E (MT040336.1), P3B (MT072865.1), P2V (MT072864.1), P5L
(MT040335.1), and P1E (MT040334.1).
A main goal of these fabrications was to 
obscure the connection between SARS-CoV-2 and 
ZC45/ZXC21. Therefore, from their perspective, the 
fabricated viruses should resemble SARS-CoV-2 more 
than ZC45 and ZXC21 do. Because ZC45 and ZXC21 
already share a 100% identity with SARSCoV-2 on the E 
protein, the fabricated viruses therefore were made to 
adopt this sequence completely as well. 
b) Important implications of this large-scale, organized 
scientific fraud
If SARS-CoV-2 is of a natural origin, no 
fabrications would be needed to suggest so. The current 
paper, therefore, corroborates our earlier paper and 
further proves that SARS-CoV-2 is a laboratory product1. 
As revealed1, the creation of SARS-CoV-2 is convenient 
by following established concepts and techniques, 
some of which (for example, restriction enzyme 
digestion) are considered classic and yet still preferred 
widely including by experts of the field35,73. A key 
component of the creation, the template virus 
ZC45/ZXC21, is owned by military research 
laboratories3. 
Importantly, as revealed here, multiple research 
laboratories and institutions have engaged in the 
fabrication and cover-up4-9,59. It is clear that this was an 
operation orchestrated by the CCP government.  
In addition, raw sequencing reads for RaTG13, 
which were integral parts of the fabrication, were 
obtained in 2017 and 201824,33. Furthermore, manuscript 
reporting the falsified coronavirus infections of Malayan 
pangolins was submitted for publication in September 
201959. Evidently, the cover-up had been planned and 
initiated before the COVID-19 outbreak. Therefore, the 
unleashing of the virus must be a planned execution 
rather than an accident. 
c) SARS-CoV-2 is an Unrestricted Bioweapon
Although it is not easy for the public to accept 
SARS-CoV-2 as a bioweapon due to its relatively low 
lethality, this virus indeed meets the criteria of a 
bioweapon as described by Dr. Ruifu Yang. Aside from 
his appointment in the AMMS, Dr. Yang is also a key 
member of China’s National and Military Bioterrorism 
Response Consultant Group and had participated in the 
investigation of the Iraqi bioweapon program as a 
member of the United Nations Special Commission 
(UNSCOM) in 1998. In 2005, Dr. Yang specified the 
criteria for a pathogen to qualify as a bioweapon74:   
1. It is significantly virulent and can cause large scale 
casualty. 
2. It is highly contagious and transmits easily, often 
through respiratory routes in the form of aerosols. 
The most dangerous scenario would be that it 
allows human-to-human transmission. 
3. It is relatively resistant to environmental changes, 
can sustain transportation, and is capable of 
supporting targeted release. 
All of the above have been met by SARS-CoV-2: 
it has taken millions of lives, led to numerous 
hospitalizations, and left many with sequela and various 
complications; it spreads easily by contact, droplets, 
and aerosols via respiratory routes and is capable of 
transmitting from human to human75-77, the latter of
which was initially covered up by the CCP government 
and the WHO and was first revealed by Dr. Li-Meng Yan 
on January 19th, 2020 on Lude Press78; it is temperature-
insensitive (unlike seasonal flu) and remains viable for a 
long period of time on many surfaces and at 4°C (e.g. 
the ice/water mixture)79,80.   
Adding to the above properties is its high rate of 
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SARS-CoV-2 extremely challenging. In addition, the 
transmissibility, morbidity, and mortality of SARS-CoV-2 
also resulted in panic in the global community, 
disruption of social orders, and decimation of the 
world’s economy. The range and destructive power of 
SARS-CoV-2 are both unprecedented.   
Clearly, SARS-CoV-2 not only meets but also 
surpasses the standards of a traditional bioweapon. 
Therefore, it should be defined as an Unrestricted 
Bioweapon. 
d) The current pandemic is an attack on humanity
The scientific evidence and records indicate 
that the current pandemic is not a result of accidental 
release of a gain-of-function product but a planned 
attack using an Unrestricted Bioweapon. The current 
pandemic therefore should be correspondingly 
considered as a result of Unrestricted Biowarfare.  
Under such circumstances, the infected 
population are being used, unconsciously, as the 
vectors of the disease to facilitate the spread of the 
infection. The first victims of the attack were the Chinese 
people, especially those in the city of Wuhan. At the
initial stage, the hidden spread in Wuhan could have 
also served another purpose: the final verification of the 
bioweapon’s functionality, an important aspect of which 
is the human-to-human transmission efficiency. Upon 
the success of this last step, targeted release of the 
pathogen might have been enabled. 
Given the global presence of SARS-CoV-2 and 
the likelihood of its long-term persistence, it is 
appropriate to say that this attack was on the humanity 
as a whole and has put its fate at risk.
e) Actions need to be taken to combat the current 
pandemic and save the future of humanity
Given the CCP’s role here, it is of paramount 
importance that the CCP is held accountable for its 
actions. In addition, the world needs to find out what 
other variants of SARS-CoV-2 exist in the CCP-controlled 
laboratories, whether or not SARS-CoV-2 or its variant(s) 
are still being actively released, whether or not re-
infection of SARS-CoV-2 leads to worsened outcomes 
due to inefficient immunity and/or antibody dependent 
enhancement (ADE)81-83, and whether other weaponized 
pathogens are owned by the CCP as a result of their 
excessive, state-stimulated efforts in collecting novel 
animal pathogens and studying their potentials in 
zoonosis 3,25,26,28,32,36,37,84-114.   
It is also of paramount importance that all the 
hidden knowledge of SARS-CoV-2 be brought out as 
soon as possible. As illustrated in our earlier paper, 
although a template virus was used, the creation of 
SARS-CoV-2 must have involved introducing changes to 
the template sequence through DNA synthesis (steps 1 
and 4 in part 2 of our earlier paper)1. Such a practice 
can be safely guided by multi-sequence alignment of 
available SARS and SARS-like coronavirus sequences. 
The process of this practice has been illustrated115, and
both syn mutations and amino acid (non-syn) mutations 
at variable positions/regions would be introduced. From 
the perspective of the responsible scientists, these 
changes are necessary because, otherwise, the 
engineered nature of the virus and its connection to its 
template would be evident. However, importantly, the 
introduced changes might have also altered the 
functions of the various viral components, which could 
be either by design or unintended. Nonetheless, it 
remains to be answered whether or how the introduced 
changes might be responsible for the various lasting 
complications that many COVID-19 patients experience 
and what barriers these changes might pose to the 
development of effective vaccines and other antiviral 
therapeutics. It is reasonable to believe that the 
responsible laboratories under the control of the CCP 
have been engaged in this research for a long period of 
time and therefore keep in possession a considerable 
amount of concealed knowledge of SARS-CoV-2. Some 
of the knowledge may provide answers to questions that 
need to be addressed urgently in the global combat 
against COVID-19. Such hidden knowledge ought to be 
made available to the world immediately. 
What also need to be held accountable are the 
individuals and groups within certain organizations and 
institutions in the fields of public health and academic 
research, who knowingly and collaboratively facilitated 
the CCP’s misinformation campaign and misled the 
world. On January 18th and 19th, 2020, Dr. Li-Meng Yan, 
then anonymously, first revealed that SARS-CoV-2 is of 
a laboratory origin78,116. Immediately afterwards, on 
January 20th, Dr. Zhengli Shi submitted her manuscript 
to Nature and reported the first fabricated virus, 
RaTG134. Since then, many virus fabrications have taken 
place and all of them were published as peer-reviewed 
articles on top scientific journals4-9. Subsequently, based 
on such reports, influential opinion articles promoting 
the natural origin theory have then been published by 
prominent scientists and international organizations on 
such and other high-profile platforms10,117-120.  
In contrast to the rigorous promotion of the 
natural origin theory, strict censorship has been placed 
by these and other journals on manuscripts discussing 
a possible laboratory origin of SARS-CoV-218,121. Our 
earlier report1, which was one of such manuscripts and 
published as a preprint article, also faced unfounded 
criticisms dressed as unbiased peer reviews from two 
groups of scientists led by Drs. Robert Gallo and Nancy 
Connell, respectively122,123 (our point-to-point responses 
are being prepared and will be published soon). As a 
result of this collaborative efforts, the public has been 
largely removed from the truth about COVID-19 and 
SARS-CoV-2, which has led to misjudgments, delayed 
actions, and greater sufferings of the global community. 
It is imperative to investigate the scientists, laboratories, 
institutions, and relevant collaborators responsible for 
the creation of SARS-CoV-2 and for the 
fabrications/cover-up. It is also imperative to investigate 
the relevant individuals in the WHO, at the relevant 
scientific journals, in the relevant funding agencies, and 
in other relevant bodies, which have facilitated the 
creation of SARSCoV-2 and the scientific cover-up of its 
true origin while under full awareness of the nature of 
these operations. Finally, it also needs to be 
investigated which ones of the scientists engaged in the 
promotion of the natural origin theory were purely misled 
by the scientific fraud and which ones were colluding 
with the CCP government.   
The time has come that the world faces the truth 
of COVID-19 and takes actions to save the future of 
humanity.   
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